Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127252932 | 12725293 | 2 | F | 20160826 | 20160908 | 20160909 | EXP | CA-PFIZER INC-2016416608 | PFIZER | 66.00 | YR | M | Y | 0.00000 | 20160909 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127252932 | 12725293 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 25 MG, WEEKLY | U | 11719 | 25 | MG | SOLUTION FOR INJECTION | /wk | |||||
| 127252932 | 12725293 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | UNK | U | 203214 | TABLET | ||||||||
| 127252932 | 12725293 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | U | 203214 | 5 | MG | TABLET | BID | |||||
| 127252932 | 12725293 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | U | 203214 | 5 | MG | TABLET | BID | |||||
| 127252932 | 12725293 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 1X/DAY | U | 203214 | 5 | MG | TABLET | QD | |||||
| 127252932 | 12725293 | 6 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 20235 | ||||||||||
| 127252932 | 12725293 | 7 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 1X/DAY | U | 0 | 40 | MG | QD | ||||||
| 127252932 | 12725293 | 8 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 1 DF, 2X/WEEK | U | 0 | 1 | DF | BIW | ||||||
| 127252932 | 12725293 | 9 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 200 MG, 2X/DAY | U | 0 | 200 | MG | BID | ||||||
| 127252932 | 12725293 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 5 MG, 1X/DAY | U | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127252932 | 12725293 | 1 | Rheumatoid arthritis |
| 127252932 | 12725293 | 2 | Rheumatoid arthritis |
| 127252932 | 12725293 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127252932 | 12725293 | OT |
| 127252932 | 12725293 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127252932 | 12725293 | Abdominal pain lower | |
| 127252932 | 12725293 | Diarrhoea | |
| 127252932 | 12725293 | Fatigue | |
| 127252932 | 12725293 | Hernia | |
| 127252932 | 12725293 | Pneumonia | |
| 127252932 | 12725293 | Presyncope | |
| 127252932 | 12725293 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |